Copyright
©The Author(s) 2025.
World J Gastrointest Surg. Feb 27, 2025; 17(2): 102342
Published online Feb 27, 2025. doi: 10.4240/wjgs.v17.i2.102342
Published online Feb 27, 2025. doi: 10.4240/wjgs.v17.i2.102342
Table 3 Comparison of symptom improvement (days), mean ± SD
| Symptom | Control (n = 63) | Observation (n = 64) | t | P value |
| Abdominal pain | 11.47 ± 2.15 | 8.35 ± 1.96 | 8.548 | < 0.001 |
| Diarrhea | 11.04 ± 2.47 | 8.62 ± 1.85 | 6.255 | < 0.001 |
| Rectal bleeding | 8.93 ± 1.64 | 6.32 ± 1.07 | 10.638 | < 0.001 |
| Fever | 7.68 ± 1.42 | 5.43 ± 1.15 | 9.820 | < 0.001 |
| Mucosal healing | 9.63 ± 1.86 | 6.12 ± 1.29 | 12.373 | < 0.001 |
- Citation: Yang CC, Zhang S, Zhang R, Zhao YN, Yang DW, Yang MY, Huang LJ. Application of Saccharomyces boulardii in combination with sulfasalazine in ulcerative colitis patients demonstrates significant effectiveness. World J Gastrointest Surg 2025; 17(2): 102342
- URL: https://www.wjgnet.com/1948-9366/full/v17/i2/102342.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v17.i2.102342